Last reviewed · How we verify

NCT06158555: TARGET UP

Targeted Perfusion Based Haemodynamic Management in Critically Ill Patients Using Urethral Perfusion

Status unknown NA Last updated 5 January 2024
What this trial tests

NA trial testing 250 ML NaCl 4.5 MG/ML Injection in Critically Ill in 30 participants. Status unknown.

Timeline
1 April 2023
Primary endpoint
1 June 2024
1 December 2024

Quick facts

Lead sponsorKing's College Hospital NHS Trust
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment30
Start date1 April 2023
Primary completion1 June 2024
Estimated completion1 December 2024
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

King's College Hospital NHS Trust

Who can join

18 and older, any sex, with Critically Ill. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To assess the safety and feasibility of the IKORUS device in critically ill patients and to gather exploratory data on haemodynamic coherence

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Critically Ill

Currently open trials in the same condition.

Other King's College Hospital NHS Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06158555.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing